Histopathological Evaluation of the Diversity of Cells Susceptible to H5N1 Virulent Avian Influenza Virus-Reference-Cited by-同舟云学术

Histopathological Evaluation of the Diversity of Cells Susceptible to H5N1 Virulent Avian Influenza Virus

Published:2014-01 Issue:1 Volume:184 Page:171-183
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Ogiwara Haru,Yasui Fumihiko,Munekata Keisuke,Takagi-Kamiya Asako,Munakata Tsubasa,Nomura Namiko,Shibasaki Futoshi,Kuwahara Kazuhiko,Sakaguchi Nobuo,Sakoda Yoshihiro,Kida Hiroshi,Kohara Michinori

Funder

Ministry of Health, Labour and Welfare

Ministry of Education, Culture, Sports, Science and Technology

Tokyo Metropolitan Institute of Medical Science

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference39 articles.

1. Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008;Okamatsu;Virus Genes,2010

2. Reintroduction of H5N1 highly pathogenic avian influenza virus by migratory water birds, causing poultry outbreaks in the 2010-2011 winter season in Japan;Sakoda;J Gen Virol,2012

3. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus;Claas;Lancet,1998

4. Pathology of fatal human infection associated with avian influenza A H5N1 virus;To;J Med Virol,2001

5. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans;Korteweg;Am J Pathol,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of vasculature and angiogenesis in respiratory diseases;Angiogenesis;2024-04-05

2. Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses;Journal of Virology;2024-03-19

3. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine;Scientific Reports;2024-02-20

4. Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models;iScience;2022-12

5. An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants;Frontiers in Microbiology;2022-11-18